Increased plasma levels of angiogenin and the risk of bladder carcinoma
Hua Zhao(University of Virginia), Xifeng Wu(Zhejiang Lab), Robert M. Chamberlain(City University of New York), Catherine Troisi(The University of Texas Health Science Center at Houston), Huifeng Zhang(Henan Provincial People's Hospital), Margaret R. Spitz(The University of Texas MD Anderson Cancer Center), H. Barton Grossman(The University of Texas MD Anderson Cancer Center), Marsha A. Chenoweth(The University of Texas MD Anderson Cancer Center), George L. Delclos(The University of Texas Health Science Center), Lu‐Yu Hwang(The University of Texas Health Science Center at Houston)
Cited by 39
Related Papers
HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUS
|The Lancet|1981|2.9k
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
|New England Journal of Medicine|2003|2.6k
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
|Nature Genetics|2017|804
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
|The American Journal of Human Genetics|2009|510
Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control study
|The Lancet Oncology|2016|405